Control of chronic CNS infection with the parasite Toxoplasma gondii requires an ongoing T cell 26 response in the brain. Immunosuppressive cytokines are also important for preventing lethal 27 immunopathology during chronic infection. To explore the loss of suppressive cytokine exclusively 28 during the chronic phase of infection we blocked IL-10 receptor (IL-10R). Blockade was associated with 29 widespread changes in the inflammatory response, including increased antigen presenting cell (APC) 30 activation, expansion of CD4+ T cells, and increased neutrophil recruitment to the brain, consistent with 31 previous reports. We then sought to identify regulatory mechanisms contributing to IL-10 production, 32 focusing on ICOS (inducible T cell costimulator), a molecule that promotes IL-10 production in many 33 systems. Unexpectedly, ICOS-ligand (ICOSL) blockade led to a local expansion of effector T cells in the 34 inflamed brain without affecting IL-10 production or APC activation. Instead, we found that ICOSL 35 blockade led to changes in T cells associated with their proliferation and survival. Specifically, we 36 observed increased expression of IL-2 associated signaling molecules, including CD25, STAT5 37 phosphorylation, Ki67, and Bcl-2 in T cells in the brain. Interestingly, increases in CD25 and Bcl-2 were 38 not observed following IL-10R blockade. Also unlike IL-10R blockade, ICOSL blockade led to an 39 expansion of both CD8+ and CD4+ T cells in the brain, with no expansion of peripheral T cell 40 populations or neutrophil recruitment to the brain Overall, these results suggest that IL-10 and ICOS 41 differentially regulate T cell responses in the brain during chronic T. gondii infection. 42 45 themselves. The importance of a balanced immune response is apparent in models of infection, where 46 inflammation is required for pathogen control and survival, yet amplified immune responses observed 47 after depletion of regulatory T cells or immunosuppressive cytokines often leads to exacerbated tissue 48 pathology and increased mortality [3-8]. One such immunosuppressive cytokine, IL-10, has been broadly 49 studied in the context of both tissue homeostasis and during infection, and has been shown to play a key 50 role in suppressing many aspects of an immune response. Production of IL-10 during immune responses 51 to infection has been attributed to a wide variety of cell types, including T cells, dendritic cells, 52 macrophages, NK cells, and B cells [9]. IL-10 also acts on a wide range of cell types, with one of its main 53 roles being the downregulation of MHC and costimulatory molecules in antigen presenting cells (APCs), 54 thereby preventing their full activation capacity and limiting T cell responses [10-12]. IL-10 also has 55 direct effects on T cells, limiting IFNγ and IL-2 production, as well as T cell proliferation in vitro [13, 56 14].
Introduction 43
Immune responses have intricately evolved to protect hosts from a wide range of potentially 44 harmful pathogens [1, 2] , yet these same inflammatory responses can often cause host damage 50U/mL DNase (Roche) for 1 hour at 37°C. After enzyme digestion, brain homogenate was passed 136 through a 70µm filter (Corning). To remove myelin, filtered brain homogenate was resuspended with 20 137 mL 40% percoll and spun for 25 minutes at 650g. Myelin was then aspirated and the cell pellet was 138 washed with cRPMI, then resuspended and cells were counted.
139
Spleens and lymph nodes were homogenized and passed through a 40µm filter 140 (Corning) and pelleted. Lymph node cells were then resuspended in cRPMI and counted. Spleen cells 141 were resuspended with 2 mL RBC lysis buffer (0.16 M NH 4 Cl). Following RBC lysis, spleen cells were 142 washed with media and then resuspended with cRPMI for counting.
143
For experiments in which peripheral blood was taken, mice were sacrificed and the right atrium 144 was cut in preparation for perfusion. Before perfusion, 300µL blood was collected from the chest cavity.
145
For isolation of circulating leukocytes, collected blood was put in 1mL heparin (100 USP/mL) to prevent 146 clotting. Samples were then pelleted and resuspended in 2 mL RBC lysis buffer for 2 minutes. Samples 147 were washed once with cRPMI and a second RBC lysis step was performed. Finally, blood cells were 148 resuspended in cRPMI for staining and counting. For serum isolation, blood was allowed to clot overnight 149 at 4°C. Samples were then spun at 14,000 rpm for 10 minutes to separate clotted blood from serum. After ELISAs for parasite-specific IgG were performed as previously described [37] . Briefly, Immunolon 154 4HBX ELISA plates (Thermofisher) were coated with 5 µg soluble Toxoplasma antigen (STAg) 155 overnight at 4°C. After antigen coating, plates were washed in 1x PBS with 0.1% Triton and 0.05%
156
Tween, then blocked with 10% FBS for 2 hours at room temperature. After washing, serial dilutions of temperature. ABTS peroxidase substrate solution (KBL) was then added to wells and immediately after a 160 color change plates were read on an Epoch BioTek plate reader using Gen5 2.00 software.
162
Flow cytometry 163 Single cell suspensions from collected tissues were plated in a 96-well plate. Cells were initially 164 incubated with 50µL Fc block (1µg/mL 2.4G2 Ab (BioXCell), 0.1% rat gamma globulin (Jackson 165 Immunoresearch)) for 10 minutes at room temperature. Cells were then surface stained for CD3 (145- Single cell suspensions were plated into a 96-well plate. For T cell cytokine restimulation, cells were 179 incubated at 37°C with 20 ng/mL PMA and 1 µg/mL ionomycin (Sigma) in the presence of brefeldin A 180 (Alfa Aesar). After incubation for 5 hours, cell suspensions were washed, surface stained, and fixed.
181
Cells were then incubated with an antibody against IFNγ (XMG1.2) for 30 minutes at 4°C. To 182 determine IL-10 production, Tiger mice expressing eGFP under the IL-10 promoter were used. Cells from then lightly fixed with 2% PFA for 30 minutes at room temperature. Cells were then permeabilized with 185 permeabilization buffer (eBioscience) and incubated with a biotin-conjugated α-GFP antibody (BD 186 Biosciences) for 30 minutes at 4°C. Cells were then washed and incubated with a PE-conjugated 187 streptavidin secondary antibody (eBioscience) for 30 minutes at room temperature. Cells were then fixed 188 with a fixation/permeabilization kit (eBioscience) overnight at 4°C before other intracellular staining was 189 performed. For myeloid cell cytokine restimulation, single cell suspensions were plated into a 96-well 190 plate and incubated with brefeldin A for 5 hours at 37°C before surface and intracellular staining for IL- 
203

T. gondii cyst counts 204
After mincing with a razor blade, brain tissue was passed through an 18-and 22-gauge needle. 30µL of 205 brain homogenate was then placed onto a microscope slide (VWR) and cysts were counted manually on a 206 brightfield DM 2000 LED microscope (Leica).
208
Immunohistochemistry
Brains from mice were embedded in OCT and flash frozen on dry ice. Samples were then stored at -20°C 210 until cutting. For Ki67 immunofluorescence staining, fresh frozen sections were lightly fixed in 25%
211
EtOH/75% acetone solution for 15 minutes at -20°C. Sections were then blocked in 1% PBS containing 212 2% goat serum (Jackson Immunoresearch), 0.1% triton, and 0.05% Tween 20 for 1 hour at room 213 temperature, then incubated with primary antibodies at 4°C overnight. After primary staining, sections 214 were washed with 1% PBS and incubated with secondary antibodies for 30 minutes at room temperature.
215
Finally, sections were nuclear stained with DAPI (Thermo Scientific) for 5 minutes at room temperature.
216
Sections were then covered with aquamount (Lerner Laboratories) and coverslips (Fisherbrand).
217
For pSTAT5 immunofluorescence staining, fresh frozen sections were fixed in 3.2% PFA for 20 218 minutes at room temperature and then permeabilized with ice cold 90% methanol for 10 minutes at -20°C
219
[31]. Sections were then incubated with blocking buffer and an anti-pSTAT5 (D47E7) (Cell Signaling 220 Technologies) primary antibody as described above. After primary antibody staining, pSTAT5 signal was 221 amplified using an anti-rabbit biotinylated antibody (Jackson Immunoresearch) before using a 222 streptavidin secondary antibody. All images were captured using a DMI6000 B widefield microscope 223 with a Hamamatsu C10600 Orca R 2 digital camera (Leica), and visualized using Metamorph software.
224
Images were then analyzed using Image J software.
225
For quantification of the number of Ki67-or pSTAT5-expressing cells, 12-15 equal-sized 226 pictures were taken (40x) within each brain slice, and the numbers of Ki67+ or pSTAT5+ CD4+ or CD8+ 227 cells were counted in each image. Numbers from each picture were then averaged and reported as the 228 average number of Ki67+ or pSTAT5+ per 100µm 2 or 500µm 2 per mouse, respectively. 
232
(v. 7.0a) using a Student's t test. In some cases, multiple experiments from different infection dates were
Results 241
Blockade of IL-10R during chronic T. gondii infection leads to broad changes in the immune response 242 and results in fatal immunopathology in brain.
243
During chronic infection with T. gondii, both effector T cells and T regs recruited to the brain are 244 capable of producing IL-10 [38]. Previously published results have shown a requirement for IL-10 245 signaling to limit fatal immunopathology in both the acute and chronic stages of infection [3, 21, 39, 40] .
246
Despite the necessity for IL-10 over the course of infection with T. gondii, previous studies addressing the 247 role of IL-10 in the chronic phase of infection relied on total IL-10 knockout mice, which succumb to 248 fatal immunopathology during the first two weeks of infection [41] . In order for these mice to survive to 249 the chronic stage of infection, the anti-parasitic drug sulfadiazine must be administered for the first two 250 weeks of infection in order to limit parasite replication and dissemination. These previously published 251 studies reported that, after sulfadiazine treatment, IL-10 knockout mice subsequently presented with 252 CD4+ T cell dependent lethal immunopathology and died late in the chronic stage of disease [21] . It is 253 still unknown, however, how a loss of IL-10 only in the chronic phase of infection influences immune 254 responses. Thus, we treated mice with an α-IL-10R blocking antibody beginning four weeks post 255 infection. Mice treated with an α-IL-10R blocking antibody during the chronic stage of infection 256 presented with overt disease and became moribund between 7 to 10 days post-treatment. H&E staining of 257 tissue sections from brains of α-IL-10R-treated mice showed increased leukocyte infiltration and 258 associated areas of necrosis not seen in control treated animals ( Figure 1A-B ). The increased numbers of 259 immune cells in the brains of α-IL-10R-treated mice included increases in both CD4+Foxp3-T cells and 260 infiltrating macrophages ( Figure 1C and Supplementary Figure 1A ). Though the increase in T cell 261 number in the brains of α-IL-10R-treated mice predominantly came from an increase in the CD4+Foxp3-
262
T cell compartment and not the CD8+ T cell compartment, an increased frequency of both Ki67+ CD4+ 263 and CD8+ effector T cells was observed ( Figure 1D ). Interestingly, using an MHCII tetramer reagent to 264 measure CD4+ T cells specific for the parasite, we observed no significant increase in the number of tetramer-positive CD4+Foxp3-T cells ( Figure 1E ). Though this analysis of antigen specificity was done 266 using only a single parasite peptide, this result suggests that IL-10R blockade in the chronic phase of 267 infection leads to the expansion of CD4+ effector T cells with potentially different antigen specificities,
268
possibly through the expansion of other parasite-specific T cell clones or self-antigen-specific T cell 269 clones.
270
The increased proliferation of effector T cells in the brain correlated with an increase in the 271 expression of costimulatory molecule CD80 on infiltrating dendritic cells and macrophages in α-IL-10R-272 treated mice ( Figure 1F ). The increased numbers of immune cells infiltrating the brain was associated 273 with increased mRNA levels of many pro-inflammatory cytokines and chemokines, including IFNγ, IL-6,
274
TNFα, IL-17, and CXCL1, demonstrating a widespread increase in inflammation in the brain in the 275 absence of IL-10 signaling ( Figure 1G-H ). An increase in IL-17 production is notable in this model, as 276 infection of wild-type mice with T. gondii typically leads to a robust Th1-polarized immune response, 277 characterized by IL-12 and IFNγ production that persists throughout the chronic stage, with very little 278 production of Th17-associated cytokines [42, 43] . Indeed, production of IL-17 has been linked to a loss of 279 IL-27-mediated regulation of immune responses during infection with T. gondii [43, 44] , suggesting a 280 pathogenic role for IL-17 in this context.
281
Production of IL-17 and CXCL1 has previously been shown to enhance recruitment of 282 neutrophils to inflamed tissues and enhance their activity in certain disease contexts [45] [46] [47] [48] [49] [50] . Neutrophil 283 recruitment to the central nervous system however, has been shown to be detrimental in many cases [50-284 52]. With the increased mRNA levels of both IL-17 and CXCL1 seen in the brain after IL-10R blockade,
285
we wanted to assess whether more neutrophils were recruited to the inflamed brain in this context. Indeed, 286 α-IL-10R-treated mice had a nearly three-fold increase in neutrophil numbers in the brain in comparison Figure 1F ). Large areas of necrosis were also observed in the livers 295 of α-IL-10R-treated mice (Supplementary Figure 1G -H), suggesting that the increased inflammatory 296 response seen following IL-10R blockade can contribute to extensive immunopathology in not only the 297 brain but peripheral tissues as well. Overall, a loss of IL-10 signaling specifically during the chronic 298 infection led to widespread immune cell activation that rapidly resulted in fatal immunopathology.
300
Blockade of ICOSL does not affect IL-10 production during chronic infection, but leads to expanded T 301 cell populations in the brain.
302
Despite clear evidence that IL-10-mediated regulation of immune responses during T. gondii 303 infection is required for host survival, little is known about what signals can induce IL-10 production in 304 activated T cells during the chronic inflammation in the brain associated with the later stages of infection.
305
Several studies have implicated a role for ICOS in inducing IL-10 production in cases of acute 306 inflammation [29, 33] . We found ICOS-expressing T cells in the brain during chronic T. gondii infection, 307 as well as infiltrating APCs expressing the ICOS-ligand (ICOSL) (Figure 2A-B ). To address whether 308 ICOS signaling is important for T cell production of IL-10 in the brain during chronic infection, we 309 treated chronically infected IL-10-eGFP reporter (Tiger) mice with the ICOSL blocking antibody.
310 Surprisingly, following ICOSL blockade in the chronic stage of infection, we did not see decreases in IL-311 10 production from either CD4+Foxp3-effector T cells or CD4+Foxp3+ regulatory T cells in the brain 312 ( Figure 2C ), and IL-10 mRNA expression from whole brain homogenate was also not decreased ( Figure   313 2D). Although levels of IL-10 were not affected after α-ICOSL treatment, we unexpectedly observed a increase in effector T cell number was not due to a loss of the local regulatory T cell population, as their 316 numbers in the brain were also increased, though to a lesser degree than the effector T cell populations 317 ( Figure 2E ). Infiltrating myeloid cell numbers were also assessed, revealing almost a two-fold increase in 318 dendritic cells in the brain compared to control treated animals ( Supplementary Figure 2A) . Though 319 increased numbers of dendritic cells were found in the brain following α-ICOSL treatment, there was no 320 effect on IL-12 production from either the dendritic cells or macrophages isolated from the brain 321 (Supplementary Figure 2B -C), suggesting that continued production of IL-12 is not reliant on ICOS-322 ICOSL interactions. We also found an increase in the number of IFNγ-producing effector T cells in the 323 brain, while mRNA levels of other pro-inflammatory cytokines and chemokines were not increased 324 ( Supplementary Figure 2D-E) . The increased numbers of T cells in the brains α-ICOSL-treated animals 325 could be seen dispersed throughout the brain parenchyma ( Figure 2F-G) , though unlike α-IL-10R treated 326 animals, ICOSL blockade was not lethal in the observed timeframe. Additionally, we observed an 327 increase in the number of tetramer-positive CD4+ effector T cells in the brain ( Figure 2H ), suggesting 328 that ICOSL blockade can lead to an expansion of parasite-specific CD4+ effector T cells in the brain.
329
Another distinction between IL-10R blockade and ICOSL blockade in the chronic phase of infection was 330 a difference in neutrophil recruitment. Whereas an increase in neutrophil numbers in the brain was seen in 331 α-IL-10R-treated mice (Figure 1 ), no significant increase was seen in α-ICOSL-treated mice ( Figure 2I -J).
332
Blockade of ICOSL primarily affected the T cell populations in the CNS and did not affect T cell 333 numbers in the spleen, draining LNs, or blood of α-ICOSL-treated mice (Supplementary Figure 2F-H) .
334
ICOS signaling has also been shown to be crucial for primary antibody responses to infection [26, 53, 335 54]. In order to assess whether the increased T cell numbers found in the brains of α-ICOSL treated 336 animals was merely a result of a change in parasite burden due to decreased antibody production, both 337 parasite-specific serum IgG titers and brain cyst burden was measured. No change was seen in either Together, these results suggest that ICOS signaling limits excessive T cell responses in the brain during 340 chronic neuroinflammation independent of changes in either IL-10 production or parasite burden. 341 342 ICOSL blockade during chronic infection is associated with increases in 343 effector T cells in the brain.
344
We next wanted to determine how lack of ICOS-ICOSL interaction during chronic inflammation 345 leads to increased numbers of T cells in the CNS. Using immunofluorescence staining for Ki67, increased 346 numbers of proliferating CD4+ and CD8+ effector T cells were found throughout the brain after ICOSL 347 blockade during chronic infection ( Figure 3A-D) . Using flow cytometry, we confirmed this increase in 348 the number of proliferating effector T cells in the brain ( Figure 3E ). Distinct from IL-10R blockade, the 349 increase in Ki67+ effector T cells in the brain following ICOSL blockade was not correlated with an 350 increase in CD80 or CD86 expression on infiltrating APCs ( Figure 3F ). Rather, ICOSL blockade led to 351 the upregulation of the pro-survival factor Bcl-2 in both CD4+Foxp3-and CD8+ effector T cells isolated 352 from the brain ( Figure 3G 
357
IL-2 signaling in T cells has been shown to support both their proliferation and survival [55, 56] .
358
Thus, we wanted to determine if the increased effector T cell proliferation and survival factor Bcl-2 359 expression could be a result of increased response to IL-2 following ICOSL blockade. After ICOSL 360 blockade, both CD4+Foxp3-and CD8+ effector T cells isolated from the brain expressed higher levels of 361 CD25, and there was a two-to three-fold increase in the total number of CD25+ effector T cells in the 362 brain compared to control treated animals ( Figure 4A-D) . In order to assess whether more of the phosphorylated STAT5 (pSTAT5), the main signaling molecule downstream of the IL-2R. Correlated 365 with the increased number of CD25+ effector T cells found in the brain with ICOSL blockade, we 366 observed increased numbers of pSTAT5-positive CD4+ and CD8+ T cells in the brains of α-ICOSL-367 treated animals ( Figure 4E-J) . Taken together, these data suggest that after ICOSL blockade, effector T 368 cells may maintain higher levels of CD25 and pSTAT5, which in turn could support increased 369 proliferation and Bcl-2 expression. 
373
While increased expression of both Bcl-2 and CD25 was seen on effector T cells in the brain 374 following ICOSL blockade, no change in Bcl-2 expression was seen in effector T cell populations 375 isolated from the brains of α-IL-10R-treated mice ( Figure 5A-B) . Additionally, increased levels of CD25
376
were not observed to the same degree with α-IL-10R treatment, as there were no changes in the levels of 377 CD25 expression on CD4+Foxp3-T cells, and only a slight increase in CD25 expression on the CD8+ T 378 cell population ( Figure 5C ). Overall, though both IL-10R blockade and ICOSL blockade resulted in 379 increased numbers of effector T cells in the brain, IL-10R blockade correlated with increased APC 380 activation and inflammatory cytokine mRNA expression, while ICOSL blockade correlated with 381 upregulation of IL-2-associated signaling molecules in effector T cells. These data further support that 382 ICOS and IL-10 signaling pathways can differentially promote regulation of effector T cell responses in 383 the brain during chronic infection.
Discussion 385
Inflammation is required to promote clearance of pathogens, but preventing excessive 386 inflammation during immune responses to infection is necessary to avoid immune-mediated tissue 387 damage [3, 15, 57] . In cases of chronic infection, this balance between inflammation and regulation must 388 be maintained over long periods of time [21, 43] , but many of the signals required to maintain control of 389 ongoing immune responses are not well understood. Our results identify one such signal, ICOS, whose 390 expression on activated T cells in the chronically infected brain provides a suppressive signal preventing 391 overabundant T cell accumulation in the inflamed CNS. We show that ICOSL blockade is associated with 392 increased expression of IL-2-associated signaling molecules CD25, pSTAT5, and Bcl-2, as well as 393 effector T cell accumulation in the brain.
394
ICOS, similar to its family member CD28, was initially characterized for its ability to amplify production [29, 31, 33, 34] . Surprisingly, we found no evidence of a local T reg defect following ICOSL 410 blockade, suggesting that T regs in the brain during chronic infection rely on signals other than ICOS to 411 support their survival and accumulation in the tissue, as well as their production of IL-10. Many activated 412 effector T cells in the brain continue to produce IL-2 in the chronic phase of infection with T. gondii, so it 413 is possible that the largely CD25+ T regs in the CNS rely mainly on IL-2 signals for their maintenance in an 414 inflamed tissue, whereas other signals are required during homeostasis when lower levels of IL-2 would 415 be present in the absence of an ongoing effector T cell response 416 One of the main differences observed between IL-10R blockade and ICOSL blockade in the 417 chronic phase of infection was the disparity in the magnitude of response. IL-10R is expressed more 418 broadly than ICOS, which may explain the widespread inflammation and lethality of IL-10R versus 419 ICOSL blockade. IL-10R is expressed by most hematopoietic cells, but can also be induced on non-420 hematopoietic cells such as fibroblasts and endothelial cells, rendering them also able to respond to IL-10 421 in inflammatory settings [64] [65] [66] . In the context of chronic T. gondii infection, this could explain why 422 changes were seen in myeloid and T cell subsets in both the brain and peripheral tissues following α-IL-
423
10R blockade. On the other hand, ICOS is only expressed on activated T cells during chronic T. gondii 424 infection, and its highest levels of expression were found in the inflamed brain. This more limited 425 expression pattern of ICOS compared to IL-10R could potentially explain the more local and specific 426 response to ICOSL blockade.
427
Another interesting aspect of the immunological phenotype seen with IL-10R blockade during 428 chronic infection was the differential effects on the accumulation of CD8+ and CD4+ effector T cell 429 populations in the brain. Following IL-10R blockade, local APCs in the brain upregulate CD80, so it is 430 possible that the CD4+ effector T cells infiltrating the brain are interacting with the highly activated local 431 fashion with infiltrating CD8+ T cells [67] . This could suggest that the activated CD8+ effector T cells in 435 the brain rely less on local restimulation through TCR-MHC and costimulatory interactions, and are 436 therefore less affected by extrinsic mechanisms of suppression through APCs in this context. Overall, it is 437 largely unknown what kinds of secondary signals, such as TCR-MHC or costimulatory interaction, are 438 required for activated T cells to carry out effector function and survive at a distal site of inflammation 439 after initial priming in secondary lymphoid organs, though it is likely these requirements differ in some 440 way for CD8+ and CD4+ T cells. Though the overall number of CD8+ effector T cells in the brain is not 441 increased, we still observed an increased frequency of Ki67+ CD8+ T cells in the brain after IL-10R 442 blockade, suggesting that this population is still responsive to IL-10-mediated suppression; perhaps 443 through an intrinsic response to IL-10 that limits their proliferative capacity. IL-10 has been shown to be 444 able to directly inhibit proliferation of CD8+ T cells in vitro [14] , as well as control the threshold of their 445 response to antigen upon initial activation [68] . Much is still unknown about the direct effects of IL-10 on 446 activated CD8+ T cells that could contribute to their regulation, though these data further suggest that 447 CD8+ effector T cells may be differentially regulated from the CD4+ effector T cell compartment in the 448 brain.
449
Two well-characterized inhibitory co-receptors are CTLA-4 and PD-1, both of which have been 450 shown to carry out their inhibitory effect at least partially through inhibition of the PI3K/Akt signaling 451 pathway [69, 70] . In this light, it is interesting to consider ICOS, which is a potent activator of the 452 PI3K/Akt pathway [71, 72] , as also providing an inhibitory signal to T cells during chronic inflammation.
453
Initial Akt activation induced during priming has been associated with increased T cell responses, both 454 through promotion of T cell proliferation and survival [73] [74] [75] . However, more recent reports have shown 455 that constitutive Akt activation in CD8+ T cells is associated with decreased expression of CD122 and 456 Bcl-2, and can promote the development of short-lived effector T cells over the development of memory both the level and duration of signaling cascades like PI3K/Akt. During the chronic neuroinflammation 460 seen with T. gondii infection, continued activation of Akt downstream of ICOS in activated T cells in the 461 brain could potentially serve as an intrinsic mechanism of controlling T cell responses by downregulating 462 IL-2-associated signaling molecules and driving effector T cells in the brain to be short-lived effectors 463 rather than memory precursors.
464
Overall, we provide evidence that ICOS costimulation provides an inhibitory signal to antigen-465 experienced effector T cells in the chronically inflamed brain. These data postulate a regulatory role for 466 ICOS in T cells during chronic neuroinflammation that is distinct and more specific than the suppressive 467 role of IL-10. Altogether, while we show that IL-10 is absolutely required for preventing exaggerated 468 immune responses and immunopathology, other regulatory signals like ICOS are also likely at play 469 during chronic inflammation that provide more fine-tuned suppression of ongoing immune responses 470 without affecting IL-10-mediated suppression. Bcl-2 on effector T cells isolated from the brains of control or α-IL-10R-treated mice (n=5-6 per 570 group, data is representative of three independent experiments and analyzed using Student's t 571 test). (C) The frequency of CD25+ effector T cells isolated from the brains of chronically 572 infected mice after α-IL-10R treatment (n= 6 per group, data is representative of two independent 573 experiments and analyzed using Student's t test). * denotes p<0.05, ** denotes p<0.01, and *** 574 denotes p<0.001 for all panels. 575 578 of this work. We acknowledge support from the Research Histology core facility at the 579 University of Virginia. We would also like to thank Marieke K. Jones for her helpful input 580 regarding relevant statistical analysis and coding, and Dr. Ken Tung for his assistance with 581 histopathological examination of tissue sections. 582
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